The interleukin-1 receptor family

Seminars in Immunology

Volumn 25, Issue 6, 2013, Pages 394-407

  Boraschi, Diana ^a   Tagliabue, Aldo ^b  

^a INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

^b AEROSPAZIO Srl   (Italy)

Author keywords

IL 1 receptors; IL 1R family; Inflammation; Interleukin 1; Resolution

Indexed keywords

INTERLEUKIN 1 RECEPTOR;

ADAPTIVE IMMUNITY; ALTERNATIVE RNA SPLICING; BINDING AFFINITY; CELL ACTIVATION; COMMENSAL; CRYSTAL STRUCTURE; DNA SEQUENCE; FIBROBLAST; GENE PRODUCT; HOST RESISTANCE; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LIGAND BINDING; MAST CELL; MENTAL DEFICIENCY; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TH2 CELL;

IL-1 RECEPTORS; IL-1R FAMILY; INFLAMMATION; INTERLEUKIN-1; RESOLUTION;

ADAPTIVE IMMUNITY; HUMANS; INFLAMMATION; INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84892866814     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2013.10.023     Document Type: Review

References (201)

1. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009, 27:519-550.
2. Dinarello C.A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011, 117:3720-3732.
3. Boraschi D. Eur Cytokine Netw 2006, 17:224-252.
4. Eloe-Fadrosh E.A., Rasko D.A. The human microbiome: from symbiosis to pathogenesis. Annu Rev Med 2013, 64:145-163.
5. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
6. Lee J., Mo J.H., Katakura K., Alkalay I., Rucker A.N., Liu Y.T., et al. Maintenance of colonic homeostasis by distintive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 2006, 8:1327-1336.
7. Garlanda C., Riva F., Polentarutti N., Buracchi C., Sironi M., De Bortoli M., et al. Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. Proc Natl Acad Sci USA 2004, 101:3522-3526.
8. Elinav E., Strowig T., Kau A.L., Henao-Mejia J., Thaiss C.A., Booth C.J., et al. NLRP6 inflammasome regulates microbial ecology and risk for colitis. Cell 2011, 145:745-757.
9. Lavelle E.C., Murphy C., O'Neill L.A., Creagh E.M. The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis. Mucosal Immunol 2010, 3:17-28.
10. O'Neill L.A. The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence. Biochem Soc Trans 2000, 28:557-563.
11. Martin M.U., Wesche H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta 2002, 1592:265-280.
12. Casanova J.L., Abel L., Quintana-Murci L. Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu Rev Immunol 2011, 29:447-491.
13. O'Neill L.A. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 2008, 226:10-18.
14. O'Neill L.A., Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 2007, 7:353-364.
15. Jeong E., Lee J.Y. Intrinsic and extrinsic regulation of innate immune receptors. Yonsei Med J 2011, 52:379-392.
16. Li X., Qin J. Modulation of Toll-interleukin 1 receptor mediated signaling. J Mol Med 2005, 83:258-266.
17. Pasare C., Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol 2005, 560:11-18.
18. Liew F.Y., Xu D., Brint E.K., O'Neill L.A.J. Negative regulation of Toll-like receptor-mediated immune responses. Nat Rev Immunol 2005, 5:446-458.
19. Qin J., Qian Y., Yao J., Cui, Li X. SIGIRR inhibits interleukin-1 receptor- and Toll-like receptor 4-mediated signaling through different mechanisms. J Biol Chem 2005, 280:25233-25241.
20. Newman R.M., Salunkhe P., Godzik A., Reed J.C. Identification and characterization of a novel bacterial virulence factor that shares homology with mammalian Toll/interleukin-1 receptor family proteins. Infect Immun 2006, 74:594-601.
21. Rana R.R., Zhang M., Spear A.M., Atkins H.S., Byrne B. Bacterial TIR-containing proteins and host innate immune system evasion. Med Microbiol Immunol 2013, 202:1-10.
22. Sims J.E., March C.J., Cosman D., Widmer M.B., MacDonald H.R., McMahan C.J., et al. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 1988, 241:585-589.
23. Dinarello C.A., Arend W., Sims J., Smith D., Blumberg H., O'Neill L., et al. IL-1 family nomenclature. Nat Immunol 2010, 11:973.
24. Rock F.L., Hardiman G., Timans J.C., Kastelein R.A., Bazan J.F. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 1998, 95:588-593.
25. Debets R., Timans J.C., Homey B., Zurawski S., Sana T.R., Lo S., et al. Two novel IL-1 family members IL-1δ and IL-1e{open}, function as an antagonist and agonist of NFKB activation through the orphan IL-1 receptor-related protein 2. J Immunol 2001, 167:1440-1446.
26. Eisenberg S.P., Evans R.J., Arend W.P., Verderber E., Brewer M.T., Hannum C.H., et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990, 343:341-346.
27. Nicklin M.J., Weith A., Duff G.W. A physical map of the region encompassing the human interleukin-1α, interleukin-1β, and interleukin-1 receptor antagonist genes. Genomics 1994, 19:382-384.
28. Greenfeder S.A., Nunes P., Kwee L., Labow M., Chizzonite R.A., Ju G. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J Biol Chem 1995, 270:13757-13765.
29. Thomas C., Bazan J.F., Garcia K.C. Structure of the activating IL-1 receptor signaling complex. Nat Struct Mol Biol 2012, 19:455-457.
30. Vigers G.P., Anderson L.J., Caffes P., Brandhuber B.J. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1β. Nature 1997, 386:190-194.
31. Schreuder H., Tardif C., Trump-Kallmeyer S., Soffientini A., Sarubbi E., Akeson A., et al. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature 1997, 386:194-200.
32. Symons J.A., Young P.R., Duff G.W. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1β precursor and loses affinity for IL-1 receptor antagonist. Proc Natl Acad Sci U S A 1995, 92:1714-1718.
33. Elzinga B.M., Twomey C., Powell J.C., Harte F., McCarthy J.V. Interleukin-1 receptor type 1 is a substrate for γ-secretase-dependent regulated intramembrane proteolysis. J Biol Chem 2009, 284:1394-1409.
34. Twomey C., Qian S., McCarthy V. TRAF6 promotes ubiquitination and regulated intramembrane proteolysis of Il-1R1. Biochem Biophys Res Commun 2009, 381:418-423.
35. Burger D., Chicheportiche R., Giri J.G., Dayer J.M. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor. J Clin Invest 1995, 96:38-41.
36. Kopf M., Bachmann M.F., Marsland B.J. Averting inflammation by targeting the cytokine environment. Nat Rev Drug Discov 2010, 9:703-718.
37. Lin H., Haley-Vicente D., Zhang J., Bernal-Fussell J., Pace A.M., Hansen D., et al. Cloning and characterization of IL-1HY2, a novel interleukin-1 family member. J Biol Chem 2001, 276:20597-20602.
38. van de Veerdonk F.L., Stoeckman A.K., Wu G., Boeckermann A.N., Azam T., Netea M.G., et al. IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proc Natl Acad Sci USA 2012, 109:3001-3005.
39. McMahan C.J., Slack J.L., Mosley B., Cosman D., Lupton S.D., Brunton L.L., et al. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 1991, 10:2821-2832.
40. Colotta F., Dower S.K., Sims J.E., Mantovani A. The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1. Immunol Today 1994, 15:562-566.
41. Orlando S., Sironi M., Bianchi G., Drummond A.H., Boraschi D., Yabes D., et al. Role of metalloproteases in the release of the IL-1 type II decoy receptor. J Biol Chem 1997, 272:31764-31769.
42. Lorenzen I., Lokau J., Dusterhoft S., Trad A., Garbers C., Scheller J., et al. The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II. FEBS Lett 2012, 586:1093-1100.
43. Reddy P., Slack J.L., Davis R., Cerretti D.P., Kozlosky C.J., Blanton R.A., et al. Functional analysis of the domain structure of tumor necrosis factor-α converting enzyme. J Biol Chem 2000, 275:14608-14614.
44. Cui X., Rouhani F.N., Hawari F., Levine S.J. Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding. J Immunol 2003, 171:6814-6819.
45. Kuhn P.-H., Marjaux E., Imhof A., De Strooper B., Haass C., Lichten Thaler S.F. Regulated intramembrane proteolysis of the interleukin-1 receptor II by α-, β-, and γ-secretase. J Biol Chem 2007, 282:11982-11995.
46. Kollewe C., Neumann D., Martin M.U. The first two N-terminal immunoglobulin-like domains of soluble human IL-1 receptor type II are sufficient to bind and neutralize IL-1β. FEBS Lett 2000, 29:189-193.
47. Neumann D., Kollewe C., Martin M.U., Boraschi D. The membrane form of the type II IL-1 receptor accounts for inhibitory function. J Immunol 2000, 165:3350-3357.
48. Colotta F., Re F., Muzio M., Bertini R., Polentarutti N., Sironi M., et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993, 261:472-475.
49. Lang D., Knop J., Wesche H., Raffetseder U., Kurrle R., Boraschi D., et al. The type II interleukin-1 receptor interacts with the interleukin-1 receptor accessory protein: a novel mechanism of regulation of the interleukin-1 responsiveness. J Immunol 1998, 161:6871-6877.
50. Malinowsky D., Lundkvist J., Laye S., Bartfai T. Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor. FEBS Lett 1998, 429:299-302.
51. van de Veerdonk F.L., Netea M.G., Dianrello C.A., Joosten L.A. Inflammasome activation and IL-1β and IL-18 processing during infection. Trends Immunol 2011, 32:110-116.
52. Hazuda D.J., Strickler J., Kueppers F., Simon P.L., Young P.R. Processing of precursor interleukin 1β and inflammatory disease. J Biol Chem 1990, 265:6318-6322.
53. Smith D.E., Hanna R., Friend D., Moore H., Chen H., Farese A.M., et al. The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. Immunity 2003, 18:87-96.
54. Liu C., Hart R.P., Liu X.-J., Clevenger W., Maki R., De Souza E.B. Cloning and characterization of an alternatively processed human type II interleukin-1 receptor mRNA. J Biol Chem 1996, 271:20965-20972.
55. Zheng Y., Humphry M., Maguire J.J., Bennett M.R., Clarke M.C.H. Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1α, controlling necrosis-induced sterile inflammation. Immunity 2013, 38:285-295.
56. Weihofen A., Martoglio B. Intramembrane-cleaving proteases: controlled liberation of proteins and bioactive peptides. Trends Cell Biol 2003, 13:71-78.
57. Kopan R., Ilagan M.X. Gamma-secretase: proteasome of the membrane?. Nat Rev Mol Cell Biol 2004, 5:499-504.
58. Peters V.A., Joesting J.J., Freund G.G. IL-1 receptor 2 (IL-1R2) and its role in immune regulation. Brain Behav Immun 2013, 32:1-8.
59. Garlanda C., Riva F., Bonavita E., Gentile S., Mantovani A. Decoys and regulatory "receptors" of the IL-1/Toll-like receptor superfamily. Front Immunol 2013, 4:180.
60. Wesche H., Korherr C., Kracht M., Falk W., Resch K., Martin M.U. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J Biol Chem 1997, 272:7727-7731.
61. Korherr C., Hofmeister R., Wesche H., Falk W. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur J Immunol 1997, 27:262-267.
62. Cullinan E.B., Kwee L., Nunes P., Shuster D.J., Ju G., McIntyre K.W., et al. IL-1 receptor accessory protein is an essential component of the IL-1 receptor. J Immunol 1998, 161:5614-5620.
63. Casadio R., Frigimelica E., Bossù P., Neumann D., Martin M.U., Tagliabue A., et al. Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1β/IL-1RI complex. FEBS Lett 2001, 499:65-68.
64. Boraschi D., Bossù P., Ruggiero P., Tagliabue A., Bertini R., Macchia G., et al. Mapping of receptor binding sites on IL-1β by reconstruction of IL-1ra-like domains. J Immunol 1995, 155:4719-4725.
65. D'Ettorre C., De Chiara G., Casadei R., Boraschi D., Tagliabue A. Functional epitope mapping of human interleukin 1β by surface plasmon resonance. Eur Cytokine Netw 1997, 8:161-171.
66. Wang D., Zhang S., Li L., Liu X., Mei K., Wang X. Structural insights into the assembly and activation of IL-1β with its receptors. Nat Immunol 2010, 11:905-912.
67. Lingel A., Weiss T.M., Niebuhr M., Pan B., Appleton B.A., Wiesmann C., et al. Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors - insight into heterotrimeric IL-1 signaling complexes. Structure 2009, 17:1398-1410.
68. Stroud R.M., Wells J.A. Mechanistic diversity of cytokine receptor signaling across cell membranes. Sci STKE 2004, re7.
69. Liu X., Hammel M., He Y., Tainer J.A., Jeng U.-S., Zhang L., et al. Structural insights into the interaction of IL-33 with its receptors. Proc Natl Acad Sci USA 2013, 110:14918-14923.
70. Wiesmann C., de Vos A.M. Variations on ligand-receptor complexes. Nat Struct Biol 2000, 7:440-442.
71. Ali S., Huber M., Kollewe C., Bischoff S.C., Falk W., Martin M.U. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci USA 2007, 104:18660-18665.
72. Chackerian A.A., Oldham E.R., Murphy E.E., Schmitz J., Pflanz S., Kastelein R.A. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol 2007, 179:2551-2555.
73. Towne J.E., Garka K.E., Renshaw B.R., Virca G.D., Sims J.E. Interleukin (IL)-1F6 IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-κB and MAPKs. J Biol Chem 2004, 279:13677-13688.
74. Jensen L.E., Muzio M., Mantovani A., Whitehead A.S. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein. J Immunol 2000, 164:5277-5286.
75. Smeets R.L., Joosten L.A.B., Arntz O.J., Bennink M.B., Takahashi N., Carlsen H., et al. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist. Arthritis Rheum 2005, 52:2202-2211.
76. Jensen L.E., Whitehead A.S. Expression of alternatively spliced interleukin-1 receptor accessory protein mRNAs is differentially regulated during inflammation and apoptosis. Cell Signal 2003, 15:793-802.
77. Barreyro L., Will B., Bartholdy B., Zhou L., Todorova T.I., Stanley R.F., et al. Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and out come correlation in AML and MDS. Blood 2012, 120:1290-1298.
78. Askmyr M., Ågerstam H., Hansen N., Gordin S., Arvanitakis A., Rissler M., et al. Selective killing of candidate AML stem cells by antibodies targeting of IL1AP. Blood 2013, 121:3709-3713.
79. Lu H.-L., Yang C.-Y., Chen H.-C., Hung C.-S., Chiang Y.-C., Tang L.-P. A novel alternatively spliced interleukin-1 receptor accessory protein mIL-1RAcP687. Mol Immunol 2008, 45:1374-1384.
80. Smith D.E., Lipsky B.P., Russell C., Ketchem R.R., Kirchner J., Hensley K., et al. A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1. Immunity 2009, 30:817-831.
81. Nguyen L., Rothwell N.J., Pinteaux E., Boutin H. Contribution of interleukin-1 receptor accessory protein b to interleukin-1 actions in neuronal cells. Neurosignals 2011, 19:222-230.
82. Huang Y., Smith D.E., Ibanez-Sandoval O., Sims J.E., Fridman W.J. Neuron-specific effects of interleukin-1β are mediated by a novel isoform of the IL-1 receptor accessory protein. J Neurosci 2011, 31:18048-18059.
83. Gosselin D., Belalvance M.-A., Rivest S. IL-1RAcPb signaling regulates adaptive mechanisms in neurons that promote their long-term serviva following excitotoxic insults. Front Immunol 2013, 7:9.
84. Costelloe C., Watson M., Murphy A., McQuilla K., Loscher C., Armstrong M.E., et al. IL-1F5 mediates anti-inflammatory activity in the brain through induction of IL-4 following interaction with SIGIRR/TIR8. J Neurochem 2008, 105:1960-1969.
85. Taylor S.L., Renshaw B.R., Garka K.E., Smith D.E., Sims J.E. Genomic organization of the interleukin-1 locus. Genomics 2002, 79:726-733.
86. Bossù P., Ciaramella A., Salani F., Vanni D., Palladino I., Caltagirone C., et al. Interleukin-18, from neuroinflammation to Alzheimer's disease. Curr Pharm Des 2010, 16:4213-4224.
87. Gutcher I., Urich E., Wolter K., Prinz M., Becher B. Interleukin 18-independent engagement of interleukin 18 receptor-α is required for autoimmune inflammation. Nat Immunol 2006, 7:946-953.
88. Carrié A., Jun L., Bienvenu T., Vinet M.C., McDonell N., Couvert P., et al. A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat Genet 1999, 23:25-31.
89. Ferrante M.I., Ghiani M., Bulfone A., Franco B. IL1RAPL2 maps to Xq22 and is specifically expressed in the central nervous system. Gene 2001, 275:217-221.
90. Yanagisawa K., Takagi T., Tsukamoto T., Tetsuka T., Tominaga S. Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett 1993, 318:83-87.
91. Trajkovic V., Sweet M.J., Xu D. T1/ST2 - an IL-1 receptor-like modulator of immune responses. Cytokine Growth Factor Rev 2004, 15:87-95.
92. Gayle M.A., Slack J.L., Bonnert T.P., Renshaw B.R., Sonoda G., Taguchi T., et al. Cloning of a putative ligand for the T1/ST2 receptor. J Biol Chem 1996, 271:5784-5789.
93. Dunn E., Sims J.E., Nicklin M.J., O'Neill L.A. Annotating genes with potential roles in the immune system: six new members of the IL-1 family. Trends Immunol 2001, 22:533-536.
94. Li H., Tago K., Io K., Kuroiwa K., Arai T., Iwahana H., et al. The cloning and nucleotide sequence of human ST2L cDNA. Genomics 2000, 67:284-290.
95. Tago K., Noda T., Hayakawa M., Iwahana H., Yanagisawa K., Yashiro T., et al. Tissue distribution and subcellular localization of a variant form of the human ST2 gene product ST2V. Biochem Biophys Res Commun 2001, 285:1377-1383.
96. Xu D., Chan W.L., Leung B.P., Hunter D., Schulz K., Carter R.W., et al. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp Med 1998, 188:1485-1492.
97. Lohning M., Stroehmann A., Coyle A.J., Grogan J.L., Lin S., Gutierrez-Ramos J.C., et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA 1998, 95:6930-6935.
98. Coyle A.J., Lloyd C., Tian J., Nguyen T., Erikkson C., Wang L., et al. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med 1999, 190:895-902.
99. Townsend M.J., Fallon P.G., Matthews D.J., Jolin H.E., McKenzie A.N. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J Exp Med 2000, 191:1069-1076.
100. Sweet M.J., Leung B.P., Kang D., Sogaard M., Schulz K., Trajkovic V., et al. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol 2001, 166:6633-6639.
101. Brint E.K., Xu D., Liu H., Dunne A., McKenzie A.N., O'Neill L.A., et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol 2004, 5:373-379.
102. Prechtel D., Harbeck N., Berger U., Hofler H., Werenskiold A.K. Clinical relevance of T1-S, an oncogene-inducible, secreted glycoprotein of the immunoglobulin superfamily, in node-negative breast cancer. Lab Invest 2001, 81:159-165.
103. Kuroiwa K., Arai T., Okazaki H., Minota S., Tominaga S. Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem Biophys Res Commun 2001, 284:1104-1108.
104. Tajima S., Oshikawa K., Tominaga S., Sugiyama Y. The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis. Chest 2003, 124:1206-1214.
105. Bhardwaj A., Januzzi J.L. ST2: a novel biomarker for heart failure. Expert Rev Mol Diagn 2010, 10:459-464.
106. Bergis D., Kassis V., Ranglack A., Koeberle V., Piiper A., Kronenberger B., et al. High serum levels of the interleukin-33 receptor soluble ST2 as a negative prognostic factor in hepatocellular carcinoma. Transl Oncol 2013, 6:311-318.
107. Gudbjartsson D.F., Bjornsdottir U.S., Halapi E., Helgadottir A., Sulem P., Jonsdottir G.M., et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009, 41:342-347.
108. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
109. Drube S., Heink S., Walter S., Löhn T., Grusser M., Gerbaulet A., et al. The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells. Blood 2010, 115:3899-3906.
110. Martin M.U. IL-33 and the IL-33 receptor complex. Semin Immunol 2013, (in press).
111. Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol 2000, 12:59-63.
112. Bossù P., Neumann D., Del Giudice E., Ciaramella A., Gloaguen I., Fantuzzi G., et al. IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease. Proc Natl Acad Sci USA 2003, 100:14181-14186.
113. Boraschi D., Dinarello C.A. IL-18 in autoimmunity. Eur Cytokine Netw 2006, 17:224-252.
114. Parnet P., Garka K.E., Bonnert T.P., Dower S.K., Sims J.E. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. J Biol Chem 1996, 271:3967-3970.
115. Torigoe K., Ushio S., Okura T., Kobayashi S., Taniai M., Kunikata T., et al. Purification and characterization of the human interleukin-18 receptor. J Biol Chem 1997, 272:25737-25742.
116. Born T.L., Thomassen E., Bird T.A., Sims J.E. Cloning of a novel receptor subunit AcPL, required for interleukin-18 signaling. J Biol Chem 1998, 273:29445-29450.
117. Yoshimoto T., Takeda K., Tanaka T., Ohkusu K., Kashiwamura S., Okamura H., et al. IL-12 up-regulates IL-18 receptor expression on T cells Th1 cells, and B cells: synergism with IL-18 for IFN-γ production. J Immunol 1998, 161:3400-3407.
118. Gerdes N., Sukhova G.K., Libby P., Reynolds R.S., Young J.L., Schonbeck U. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 2002, 195:245-257.
119. Gutzmer R., Langer K., Mommert S., Wittmann M., Kapp A., Werfel T. Human dendritic cells express the IL-18R and are chemoattracted to IL-18. J Immunol 2003, 171:6363-6371.
120. Debets R., Timans J.C., Churakowa T., Zurawski S., de Waal Malefyt R., Moore K.W., et al. Kastelein RA IL-18 receptors, their role in ligand binding and function: anti-IL-1RAcPL antibody, a potent antagonist of IL-18. J Immunol 2000, 165:4950-4956.
121. Kim S.H., Reznikov L.L., Stuyt R.J., Selzman C.H., Fantuzzi G., Hoshino T., et al. Functional reconstitution and regulation of IL-18 activity by the IL-18R β chain. J Immunol 2001, 166:148-154.
122. Kato Z., Jee J.G., Shikano H., Mishima M., Ohki I., Ohnishi H., et al. The structure and binding mode of interleukin-18. Nat Struct Biol 2003, 10:966-971.
123. Neumann D., Martin M.U. Interleukin-12 upregulates the IL-18Rβ chain in BALB/c thymocytes. J Interferon Cytokine Res 2001, 21:635-642.
124. Strengell M., Sareneva T., Foster D., Julkunen I., Matikainen S. IL-12 up-regulates the expression of genes associated with innate immunity and Th1 response. J Immunol 2002, 169:3600-3605.
125. Takei S., Hoshino T., Matsunaga K., Sakazaki Y., Sawada M., Oda H., et al. Soluble interleukin-18 receptor complex is a novel biomarker in rheumatoid arthritis. Arthritis Res Ther 2011, 13:R52.
126. Andre R., Wheeler R.D., Collins P.D., Luheshi G.N., Pickering-Brown S., Kimber I., et al. Identification of a truncated IL-18R beta mRNA: a putative regulator of IL-18 expressed in rat brain. J Neuroimmunol 2003, 145:40-45.
127. Fiszer D., Rozwadowska N., Rychlewski L., Kosicki W., Kurpisz M. Identification of IL-18RAP mRNA truncated splice variants in human testis and the other human tissues. Cytokine 2007, 39:178-183.
128. Veenbergen S., Smeets R.L., Bennink M.B., Arntz O.J., Joosten L.A., van den Berg W.B., et al. The natural soluble form of IL-18 receptor β exacerbates collagen-induced arthritis via modulation of T-cell immune responses. Ann Rheum Dis 2010, 69:276-283.
129. Kumar S., Hanning C.R., Brigham-Burke M.R., Rieman D.J., Lehr R., Khandekar S., et al. Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-γ production. Cytokine 2002, 18:61-71.
130. Bufler P., Azam T., Gamboni-Robertson F., Reznikov L.L., Kumar S., Dinarello C.A., et al. A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity. Proc Natl Acad Sci USA 2002, 99:13723-13728.
131. Novick D., Kim S.H., Fantuzzi G., Reznikov L.L., Dinarello C.A., Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999, 10:127-136.
132. Boraschi D., Lucchesi D., Hainzl S., Leitner M., Maier E., Mangelberger D., et al. IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 2011, 22:127-147.
133. Kim S.H., Azam T., Novick D., Yoon D.Y., Reznikov L.L., Bufler P., et al. Identification of amino acid residues critical for biological activity in human interleukin-18. J Biol Chem 2002, 277:10998-11003.
134. Watanabe M., Goto N., Watanabe Y., Nishiguchi S., Shimada K., Yasunga T., et al. Evolution of interleukin-18 binding proteins and interleukin-1 receptor, type II proteins. Int J Mol Med 2005, 15:561-566.
135. Xiang Y., Moss B. IL-18 binding and inhibition of interferon γ induction by human poxvirus-encoded proteins. Proc Natl Acad Sci USA 1999, 96:11537-11542.
136. Kim S.H., Eisenstein M., Reznikov L., Fantuzzi G., Novick D., Rubinstein M., et al. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA 2000, 97:1190-1195.
137. Krumm B., Meng X., Li Y., Xiang Y., Deng J. Structural basis for antagonisn of human interleukin 18 by poxvirus interleukin 18-binding protein. Proc Natl Acad Sci USA 2008, 105:20711-20715.
138. Paulukat J., Bosmann M., Nold M., Garkisch S., Kampfer H., Frank S., et al. Expression and release of IL-18 binding protein in response to IFN-γ. J Immunol 2001, 167:7038-7043.
139. Bresnihan B., Roux-Lombard P., Murphy E., Kane D., FitzGerald O., Dayer J.M. Serum interleukin 18 and interleukin 18 binding protein in rheumatoid arthritis. Ann Rheum Dis 2002, 61:726-729.
140. Novick D., Schwartsburd B., Pinkus R., Suissa D., Belzer I., Sthoeger Z., et al. A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine 2001, 14:334-342.
141. Migliorini P., Anzilotti C., Pratesi F., Quattroni P., Bargagna M., Dinarello C.A., et al. Serum and urinary levels of IL-18 and its inhibitor IL-18BP in systemic lupus erythematosus. Eur Cytokine Netw 2010, 21:264-271.
142. Lovenberg T.W., Crowe P.D., Liu C., Chalmers D.T., Liu X.J., Liaw C., et al. Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL 1R-rp2). J Neuroimmunol 1996, 70:113-122.
143. Towne J.E., Renshaw B.R., Douangpanya J., Lipsky B.P., Shen M., Gabel C.A., et al. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity. J Biol Chem 2011, 286:42594-42602.
144. Magne D., Palmer G., Barton J.L., Mézin F., Talabot-Ayer D., Bas S., et al. The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes. Arthritis Res Ther 2006, 8:R80.
145. Blumberg H., Dinh H., Trueblood E.S., Pretorius J., Kugler D., Weng N., et al. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med 2007, 204:2603-2614.
146. Ramadas R.A., Ewart S.L., Medoff B.D., LeVine A.M. Interleukin-1 family member 9 stimulates chemokine production and neutrophil influx in mouse lungs. Am J Respir Cell Mol Biol 2011, 44:134-145.
147. Ramadas R.A., Ewart S.L., Iwakura Y., Medoff B.D., LeVine A.M. IL-36α exerts pro-inflammatory effects in the lungs of mice. PLoS ONE 2012, 7:e45784.
148. Vigne S., Palmer G., Lamacchia C., Martin P., Talabot-Ayer D., Rodriguez E., et al. IL-36R ligands are potent regulators of dendritic and T cells. Blood 2011, 118:5813-5823.
149. Mutamba S., Allison A., Mahida Y., Barrow P., Foster N. Expression of IL-1Rrp2 by human myelomonocytic cells is unique to DCs and facilitates DC maturation by IL-1F8 and IL-1F9. Eur J Immunol 2012, 42:607-617.
150. Berglöf E., Andre R., Renshaw B.R., Allan S.M., Lawrence C.B., Rothwell N.J., et al. IL-1Rrp2 expression and IL-1F9 (IL-1H1) actions in brain cells. J Neuroimmunol 2003, 139:36-43.
151. Andre R., Lerouet D., Kimber I., Pinteaux E., Rothwell N.J. Regulation of expression of the novel IL-1 receptor family members in the mouse brain. J Neurochem 2005, 95:324-330.
152. Wang P., Meinhardt B., Andre R., Renshaw B.R., Kimber I., Rothwell N.J., et al. The interleukin-1-related cytokine IL-1F8 is expressed in glial cells, but fails to induce IL-1β signalling responses. Cytokine 2005, 29:245-250.
153. Thomassen E., Renshaw B.R., Sims J.E. Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily. Cytokine 1999, 11:389-399.
154. Polentarutti N., Penton Rol G., Muzio M., Bosisio D., Camnasio M., Riva F., et al. Unique pattern of expression and inhibition of IL-1 signaling by the IL-1 receptor family member TIR8/SIGIRR. Eur Cytokine Netw 2003, 14:211-218.
155. Wald D., Qin J., Zhao Z., Qian Y., Naramura M., Tian L., et al. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signalling. Nat Immunol 2003, 4:920-927.
156. Gu Y.F., Fang Y., Jin Y., Dong W.R., Xiang L.X., Shao J.Z. Discovery of the DIGIRR gene from teleost fish: a novel Toll-IL-1 receptor family member serving as a negative regulator of IL-1 signaling. J Immunol 2011, 187:2514-2530.
157. Gong J., Wei T., Stark R.W., Jamitzky F., Heckl W.M., Anders H.J., et al. Inhibition of Toll-like receptors TLR4 and 7 signaling pathways by SIGIRR: a computational approach. J Struct Biol 2010, 169:323-330.
158. Bulek K., Swaidani S., Qin J., Lu Y., Gulen M.F., Herjan T., et al. The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response. J Immunol 2009, 182:2601-2609.
159. Jin H., Gardner R.J., Viswesvaraiah R., Muntoni F., Roberts R.G. Two novel members of the interleukin-1 receptor gene family, one deleted in Xp22.1-Xp21.3 mental retardation. Eur J Hum Genet 2000, 8:87-94.
160. Born T.L., Smith D.E., Garka K.E., Renshaw B.R., Bertles J.S., Sims J.E. Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signaling. J Biol Chem 2000, 275:29946-29954.
161. Sana T.R., Debets R., Timans J.C., Bazan J.F., Kastelein R.A. Computational identification, cloning, and characterization of IL-1R9, a novel interleukin-1 receptor-like gene encoded over an unusually large interval of human chromosome Xq22.2-q22.3. Genomics 2000, 69:252-262.
162. Piton A., Michaud J.L., Peng H., Aradhya S., Gauthier J., Mottron L., et al. Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum Mol Genet 2008, 17:3965-3974.
163. Melhem N., Middleton F., McFadden K., Klei L., Faraone S.V., Vinogradov S., et al. Copy number variants for schizophrenia and related psychotic disorders in oceanic Palau: risk and transmission in extended pedigrees. Biol Psychiatry 2011, 70:1115-1121.
164. Gao X., Xi G., Niu Y., Zhang S., Fu R., Zheng Z., et al. A study on the correlation between IL1RAPL1 and human cognitive ability. Neurosci Lett 2008, 438:163-167.
165. Smith D.E., Renshaw B.R., Ketchem R.R., Kubin M., Garka K.E., Sims J.E. Four new members expand the interleukin-1 superfamily. J Biol Chem 2000, 275:1169-1175.
166. 2+-channel and neurite elongation. Proc Natl Acad Sci USA 2007, 104:9063-9068.
167. Khan J.A., Brint E.K., O'Neill L.A.J., Tong L. Crystal structure of the Toll/Interleukin-1 receptor domain of human IL-1RAPL. J Biol Chem 2004, 279:31664-31670.
168. Bahi N., Friocourt G., Carrie A., Graham M.E., Weiss J.L., Chafey P., et al. IL1 receptor accessory protein like, a protein involved in X-linked mental retardation, interacts with Neuronal Calcium Sensor-1 and regulates exocytosis. Hum Mol Genet 2003, 12:1415-1425.
169. Yoshida T., Yasumura M., Uemura T., Lee S.J., Ra M., Tagichi R., et al. IL-1 receptor accessory protein-like 1 associated with mental retardation and autism mediates synapse formation by trans-synaptic interaction with protein tyrosine phosphatase δ. J Neurosci 2011, 31:13485-13499.
170. Hayashi T., Yoshida T., Ra M., Taguchi R., Mishina M. IL1RAPL1 associated with mental retardation and autism regulates the formation and stabilization of glutamatergic synapses of cortical neurons through RhoA signaling pathway. PLoS ONE 2013, 8:e66254.
171. Meyers B.C., Kozik A., Griego A., Kuang H., Michelmore R.W. Genome-wide analysis of NBS-LRR-encoding genes in Arabidopsis. Plant Cell 2003, 15:809-834.
172. Luo C., Zheng L. Independent evolution of Toll and related genes in insects and mammals. Immunogenetics 2000, 51:92-98.
173. Johnson G.B., Brunn G.J., Tang A.H., Platt J.L. Evolutionary clues to the functions of the Toll-like family as surveillance receptors. Trends Immunol 2003, 24:19-24.
174. Ausubel F.M. Are innate immune signaling pathways in plants and animals conserved?. Nat Immunol 2005, 6:973-979.
175. Kimbrell D.A., Beutler B. The evolution and genetics of innate immunity. Nat Rev Genet 2001, 2:256-267.
176. Beck G., Ellis T.W., Truong N. Characterization of an IL-1 receptor from Asterias forbesi coelomocytes. Cell Immunol 2000, 203:66-73.
177. Gauthier M.E., Du Pasquier L., Degnan B.M. The genome of the sponge Amphimedon queenslandica provides new perspectives into the origin of Toll-like and interleukin 1 receptor pathways. Evol Dev 2010, 12:519-533.
178. Hibino T., Loza-Coll M., Messier C., Majeske A.J., Cohen A.H., Terwilliger D.P., et al. The immune gene repertoire encoded in the purple sea urchin genome. Dev Biol 2006, 300:349-365.
179. Huang S., Yuan S., Guo L., Yu Y., Li J., Wu T., et al. Genomic analysis of the immune gene repertoire of amphioxus reveals extraordinary innate complexity and diversity. Genome Res 2008, 18:1112-1126.
180. Gerber S., Cadet P., Sheenan M., Stefano G.B., Mantione K.J. Vertebrate interleukins originated in invertebrates?. Invert Surv J 2007, 4:95-100.
181. Cateni C., Paulesu L., Bigliardi E., Hamlett W.C. The interleukin 1 (IL-1) system in the uteroplacental complex of a cartilaginous fish, the smoothhound shark Mustelus canis. Reprod Biol Endocrinol 2003, 1:25.
182. Subramaniam S., Stansberg C., Olsen L., Zou J., Secombes C.J., Cunningham C. Cloning of a Salmo salar interleukin-1 receptor-like cDNA. Dev Comp Immunol 2002, 26:415-431.
183. Zou J., Grabowski P.S., Cunningham C., Secombes C.J. Molecular cloning of interleukin 1beta from rainbow trout Oncorhynchus mykiss reveals no evidence of an ice cut site. Cytokine 1999, 11:552-560.
184. Sangrador-Vegas A., Martin S.A., O'Dea P.G., Smith T.J. Cloning and characterization of the rainbow trout (Oncorhynchus mykiss) type II interleukin-1 receptor cDNA. Eur J Biochem 2000, 267:7031-7037.
185. Huising M.O., Stet R.J.M., Savelkoul H.F.J., Verburg-van Kemenade B.M.L. The molecular evolution of the interleukin-1 family of cytokines; IL-18 in teleost fish. Dev Comp Immunol 2004, 28:395-413.
186. Stansberg C., Subramaniam S., Collet B., Secombes C.J., Cunningham C. Cloning of the Atlantic salmon (Salmo salar) IL-1 receptor associated protein. Fish Shellfish Immunol 2005, 19:53-65.
187. Stansberg C., Subramaniam S., Olsen L., Secombes C.J., Cunningham C. Cloning and characterisation of a putative ST2L homologue from Atlantic salmon (Salmo salar). Fish Shellfish Immunol 2003, 15:211-224.
188. Jantra S., Bigliardi E., Brizzi R., Ietta F., Bechi N., Paulesu L. Interleukin 1 in oviductal tissue of viviparous, oviparous, and ovuliparous species of amphibians. Biol Reprod 2007, 76:1009-1015.
189. Paulesu L., Romagnoli R., Marchetti M., Cintorino M., Ghiara P., Guarino F.M., et al. Cytokines in the viviparous reproduction of squamate reptiles: interleukin-1α (IL-1α) and IL-1β in placental structures of a skink. Placenta 1995, 16:193-205.
190. Guida S., Heguy A., Melli M. The chicken IL-1 receptor: differential evolution of the cytoplasmic and extracellular domains. Gene 1992, 111:239-243.
191. Ottaviani E., Franchini A., Franceschi C. Presence of several cytokine-like molecule in molluscan hemocytes. Biochem Biophys Res Commun 1993, 195:984-988.
192. Hughes T.K., Smith E.M., Chin R., Cadet P., Sinisterra J., Leung M.K., et al. Interaction of immunoreactive monokines (interleukin 1 and tumor necrosis factor) in the bivalve mollusc Mytilus edulis. Proc Natl Acad Sci USA 1990, 87:4426-4429.
193. Beck G., Habicht G.S. Purification and biochemical characterization o fan invertebrate interleukin1. Mol Immunol 1991, 28:577-584.
194. Zhang S.M., Adema C.M., Kepler T.B., Loker E.S. Diversification of Ig superfamily genes in an invertebrate. Science 2004, 305:251-254.
195. Murzin A.G., Lesk A.M., Chothia C. Beta-trefoil fold patterns of structure and sequence in the Kunitz inhibitors interleukins-1β and 1α and fibroblast growth factors. J Mol Biol 1992, 223:531-543.
196. Feng J., Li M., Huang Y., Xiao Y. Symmetric key structural residues in symmetric proteins beta-trefoil fold. PLoS ONE 2010, 5:1413-1418.
197. Sweet R.M., Wright H.T., Janin J., Chothia C.H., Blow D.M. Crystal structure of the complex of porcine trypsin with soybean trypsin inhibitor (Kunitz) at 2.6-Å resolution. Biochemistry 1974, 4212-4213.
198. McLachlan A.D. Three-fold structural pattern in the soybean trypsin inhibitor (Kunitz). J Mol Biol 1979, 133:557-563.
199. Drenth J., Jansonius J.N., Koekoek R., Wolthers B.G. The structure of papain. Adv Protein Chem 1971, 25:79-115.
200. Vainshtein B.K., Melik-Adamyan W.R., Barynin V.V., Vagin A.A., Grebenko A.I., Borisov V.V., et al. Three-dimensional structure of catalase from Penicillium vitale at 2.0Å resolution. J Mol Biol 1986, 188:49-61.
201. Habazettl J., Gondol D., Wiltscheck R., Otlewski J., Schleicher M., Holak T.A. Structure of hisactophilin is similar to interleukin-1 β and fibroblast growth factor. Nature 1992, 359:855-858.